BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19756733)

  • 1. Behçet disease: treatment of vascular involvement in children.
    Ozen S; Bilginer Y; Besbas N; Ayaz NA; Bakkaloglu A
    Eur J Pediatr; 2010 Apr; 169(4):427-30. PubMed ID: 19756733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Behçet's syndrome: an update.
    Emmi G; Bettiol A; Silvestri E; Di Scala G; Becatti M; Fiorillo C; Prisco D
    Intern Emerg Med; 2019 Aug; 14(5):645-652. PubMed ID: 30499073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does anticoagulation in combination with immunosuppressive therapy prevent recurrent thrombosis in Behçet's disease?
    Erol S; Gürün Kaya A; Arslan F; Hasanzade H; Daştan AO; Çiledağ A; Eriş Gülbay B; Kaya A; Özdemir Kumbasar Ö; Çelik G; Acıcan T
    J Investig Med; 2024 Apr; 72(4):387-391. PubMed ID: 38357865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?
    Roriz M; Crassard I; Lechtman S; Saadoun D; Champion K; Wechsler B; Chabriat H; Sène D
    Rev Neurol (Paris); 2018 Mar; 174(3):162-166. PubMed ID: 29523353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF; Al-Hemidan AI
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's disease: How to diagnose and treat vascular involvement.
    Seyahi E
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):279-295. PubMed ID: 27886800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Behçet syndrome: from pathogenesis to treatment.
    Bettiol A; Alibaz-Oner F; Direskeneli H; Hatemi G; Saadoun D; Seyahi E; Prisco D; Emmi G
    Nat Rev Rheumatol; 2023 Feb; 19(2):111-126. PubMed ID: 36544027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-Behçet syndrome presenting as acute meningeal syndrome.
    Kara B; Somer A; Pişkin S; Aydinli N; Salman N; Yalçin I
    J Infect; 2006 Apr; 52(4):e120-3. PubMed ID: 16197999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
    Yoshida S; Takeuchi T; Yoshikawa A; Ozaki T; Fujiki Y; Hata K; Makino S; Hanafusa T
    Mod Rheumatol; 2012 Sep; 22(5):791-5. PubMed ID: 22245952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.
    Emmungil H; Yaşar Bilge NŞ; Küçükşahin O; Kılıç L; Okutucu S; Gücenmez S; Kalyoncu U; Kaşifoğlu T; Turgay M; Aksu K
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S87-92. PubMed ID: 25068833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular involvement in Behçet's disease].
    Desbois AC; Wechsler B; Cluzel P; Helft G; Boutin D; Piette JC; Cacoub P; Saadoun D
    Rev Med Interne; 2014 Feb; 35(2):103-11. PubMed ID: 24434015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Challenge of Treating Pulmonary Vasculitis in Behçet Disease: Two Pediatric Cases.
    Demir S; Sag E; Kaya Akca U; Hazirolan T; Bilginer Y; Ozen S
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31320468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome].
    Kaatz M; Görnig M; Bocker T; Zouboulis CC; Wollina U
    Dtsch Med Wochenschr; 1998 Feb; 123(8):217-22. PubMed ID: 9526491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of abdominal aortic aneurysms in Behçet disease: a retrospective analysis.
    Sahutoglu T; Artim Esen B; Aksoy M; Kurtoglu M; Poyanli A; Gul A
    Rheumatol Int; 2019 Jun; 39(6):1061-1067. PubMed ID: 30888471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease.
    Melillo N; Sangle S; Stanford MR; Andrews TC; D'Cruz DP
    Clin Rheumatol; 2007 Aug; 26(8):1365-7. PubMed ID: 17063282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of anti-tumor necrosis factor α monoclonal antibodies in 16 patients with severe/refractory vasculo Behcet's disease].
    Li L; Liu JJ; Yu X; Wu D; Zhang SZ; Yang YJ; Zhou JX; Zeng XF; Zhang FC; Zheng WJ
    Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):303-308. PubMed ID: 32209197
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurologic manifestations of Behçet disease: rheumatology experience.
    Dinler M; Yaşar Bilge NŞ; Arslan AE; Yıldırım R; Kaşifoğlu T
    Z Rheumatol; 2024 Feb; 83(Suppl 1):200-205. PubMed ID: 37848717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients.
    Saadoun D; Asli B; Wechsler B; Houman H; Geri G; Desseaux K; Piette JC; Huong DLT; Amoura Z; Salem TB; Cluzel P; Koskas F; Resche-Rigon M; Cacoub P
    Medicine (Baltimore); 2012 Jan; 91(1):18-24. PubMed ID: 22198498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent right atrial thrombosis due to Behçet disease.
    Kuno T; Tamura Y; Ono T; Murata M; Kuwana M; Satoh T; Fukuda K
    Can J Cardiol; 2014 Oct; 30(10):1250.e1-3. PubMed ID: 25174856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial involvement in Behcet's disease: a series of 7 cases].
    Ketari Jamoussi S; Chaaba H; Ben Dhaou B; Boussema F; Kochbati S; Cherif O; Rokbani L
    Tunis Med; 2009 Sep; 87(9):583-8. PubMed ID: 20180378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.